110 related articles for article (PubMed ID: 35448927)
21. 18F-FDG PET/CT imaging features of patients with multicentric Castleman disease.
Jiang Y; Hou G; Zhu Z; Huo L; Li F; Cheng W
Nucl Med Commun; 2021 Jul; 42(7):833-838. PubMed ID: 33741858
[TBL] [Abstract][Full Text] [Related]
22. Utility of
Chen J; Li XL; Huang M
Clin Radiol; 2024 Mar; 79(3):205-212. PubMed ID: 38218705
[TBL] [Abstract][Full Text] [Related]
23. [
Porter JC; Ganeshan B; Win T; Fraioli F; Khan S; Rodriguez-Justo M; Endozo R; Shortman RI; Hoy LR; Maher TM; Groves AM
J Nucl Med; 2024 Apr; 65(4):617-622. PubMed ID: 38485275
[TBL] [Abstract][Full Text] [Related]
24.
Cordoba R; Sánchez-García J; Domingo-Domenech E; López Jiménez J; Martínez Pozo A; Carpio C; Bendaña Á; González AJ; González de Villambrosia S; Gómez Codina J; Navarro B; Rodríguez G; Naves A; Baeza L; Martín García-Sancho A
Expert Rev Hematol; 2024; 17(1-3):95-100. PubMed ID: 38299464
[TBL] [Abstract][Full Text] [Related]
25.
Zhang X; Huang W; Qiu Y; Chen Z; Song L; Yang Q; Kang L
Am J Nucl Med Mol Imaging; 2023; 13(6):245-258. PubMed ID: 38204603
[TBL] [Abstract][Full Text] [Related]
26. Distinguishing Kikuchi-Fujimoto disease from lymphoma in patients by clinical and PET/CT features.
Cheng MH; Xie LJ
Medicine (Baltimore); 2024 Apr; 103(16):e37779. PubMed ID: 38640333
[TBL] [Abstract][Full Text] [Related]
27. FDG PET/CT Showing a Primary Vaginal NK/T Cell Lymphoma.
Tang P; Wang R; Su M; Shen G; Tian R
Clin Nucl Med; 2022 Mar; 47(3):273-274. PubMed ID: 34619705
[TBL] [Abstract][Full Text] [Related]
28. Clinical Application of
Zirakchian Zadeh M
Clin Lymphoma Myeloma Leuk; 2023 Nov; 23(11):800-814. PubMed ID: 37558532
[TBL] [Abstract][Full Text] [Related]
29. Chemokine Receptor PET/CT Provides Relevant Staging and Management Changes in Marginal Zone Lymphoma.
Duell J; Buck AK; Hartrampf PE; Schlötelburg W; Schneid S; Weich A; Dreher N; Lapa C; Kircher M; Higuchi T; Samnick S; Serfling SE; Raderer M; Rasche L; Einsele H; Topp MS; Kosmala A; Werner RA
J Nucl Med; 2023 Dec; 64(12):1889-1894. PubMed ID: 37797975
[TBL] [Abstract][Full Text] [Related]
30. Mast Cell Sarcoma Mimicking Lymphoma or Metastatic Disease on 18 F-FDG PET/CT.
Rosar F; Ezziddin S; Bittenbring JT; Christofyllakis K; Burgard C
Clin Nucl Med; 2024 May; 49(5):464-465. PubMed ID: 38456450
[TBL] [Abstract][Full Text] [Related]
31. The value of 18F-FDG PET/CT in Langerhans cell histiocytosis.
An R; Ma X; Wang Y
Ann Nucl Med; 2024 Mar; 38(3):238-245. PubMed ID: 38217750
[TBL] [Abstract][Full Text] [Related]
32.
Kroeze E; Padilla LA; Burkhardt B; Attarbaschi A; von Mersi H; Kebudi R; Nievelstein RAJ; Tolboom N; Hagleitner MM; Kuiper RP; Beishuizen A; Loeffen JLC
Pediatr Blood Cancer; 2023 Nov; 70(11):e30642. PubMed ID: 37638834
[No Abstract] [Full Text] [Related]
33. Comparative analysis of upper aerodigestive tract and non-upper aerodigestive tract in NK/T-cell lymphoma.
Liu X; Cao D; Liu H; Ke X; Liu X; Xu X
Clin Transl Oncol; 2024 Jan; 26(1):214-224. PubMed ID: 37351807
[TBL] [Abstract][Full Text] [Related]
34. A rare case of primary cardiac diffuse large B-cell lymphoma imaged with
Huang W; Zheng Z; Zhang Y; Qiu Y; Peng Y; Yang Q; Wang W; Kang L
Front Med (Lausanne); 2024; 11():1373773. PubMed ID: 38576712
[TBL] [Abstract][Full Text] [Related]
35. A Case of Nasal Extranodal NK/T-cell Lymphoma of Lower Limb Muscle Revealed by 18F-FDG PET/CT.
Hu X; Li W; Li D; Wang P; Cai J
Curr Med Imaging; 2024 Mar; ():. PubMed ID: 38454766
[TBL] [Abstract][Full Text] [Related]
36. [Clinicopathological features of intravascular peripheral T-cell lymphoma].
Guan X; Yang YC; Qi Y; Gong WC; Xu XY; Wang YL; Guo YH; Luo Y; Sun L; Fu K; Meng B
Zhonghua Xue Ye Xue Za Zhi; 2021 Jul; 42(7):583-590. PubMed ID: 34455746
[No Abstract] [Full Text] [Related]
37. Early Hyperprogression of Lymphoma Detected by 18 F-FDG PET/CT After Chimeric Antigen Receptor T-Cell Therapy.
He L; Deng Y; Deng Y; Xie H; Zhang W
Clin Nucl Med; 2023 Mar; 48(3):256-258. PubMed ID: 36634320
[TBL] [Abstract][Full Text] [Related]
38. "Wandering Spleen" With Lymphomatous Involvement.
Cagliyan F; Balaban Genc ZC; Dede F; Erdil TY
Clin Nucl Med; 2024 Jan; 49(1):71-73. PubMed ID: 37976521
[TBL] [Abstract][Full Text] [Related]
39. Optimization of immune checkpoint inhibitor treatment planning for relapsed or refractory extranodal NK/T cell lymphoma.
Yoon SE; Cho H; Berning P; Cho J; Kim HY; Yoon DH; Schmit N; Kim SJ; Kim WS
Ann Hematol; 2024 May; ():. PubMed ID: 38730207
[TBL] [Abstract][Full Text] [Related]
40. The performance and applied value of
Pan B; Zhu X; Xie Q
Am J Nucl Med Mol Imaging; 2023; 13(5):217-224. PubMed ID: 38023819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
